Short sellers hit back at Cassava lawsuit against them: ‘We stand behind everything we wrote’
admin The defendants in a defamation lawsuit brought by Cassava Sciences have hit back at the…
Read Morelife sciences
Moderna stock falls after earnings miss by a wide margin and company cuts sales outlook by up to $3 billion
Moderna Inc. shares moved lower Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter…
Read MoreWeekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion
The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from…
Read MoreWeekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion
The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from…
Read MoreHere’s how top CEOs are opening up their wallets for J.D. Vance and other candidates in key Senate races
By one metric, J.D. Vance could be considered the favorite among CEOs of S&P 500…
Read MoreHere are the S&P 500 CEOs spending the most on the midterm elections
S&P 500 chief executive officers have opened up their wallets for this month’s midterm elections,…
Read MoreWhat neuroscientists have learned about rejuvenating the aging brain—and what you can do too
We all understand that no magic elixir can stop or even slow the human brain…
Read MoreGSK lifts 2022 view after third quarter sales of $8.99 billion beat forecasts
GSK PLC on Wednesday raised its guidance for the full year and posted rising sales…
Read MorePoseidon’s $10.9 billion take-private deal for Atlas Corp. sets sail at sweetened price
Atlas Corp. said Tuesday it has agreed to be acquired by Poseidon Acquisition Corp. in…
Read More
Opinion: Investors in drug stocks should ignore dubious valuations based on rigged methodologies
The investment firm Morningstar has announced that it will now pick drug stocks based upon…
Read More